Drug
Granisetron Transdermal System
Granisetron Transdermal System: highest development phase Phase 1, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| granisetron transdermal system NCT01596400 | Phase 1 | Chemotherapy Induced Nausea and Vomiting |
Latest
No recent events.
Follow Granisetron Transdermal System on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.